BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Diagnosis
42 results:

  • 1. cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
    Drevinskaite M; Kaceniene A; Patasius A; Stukas R; Germanavicius A; Miseikyte E; Urbonas V; Smailyte G
    Acta Psychiatr Scand; 2024 Mar; 149(3):234-243. PubMed ID: 38173088
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
    Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
    Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation.
    Xu Y; Wang Y; Chen Q; Yao T; Qiu J; Ni L; Chen H; Liang T
    Pancreatology; 2023 Dec; 23(8):1003-1013. PubMed ID: 37923686
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
    Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
    Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Oncological management dilemma: a rare presentation of hairy cell leukaemia with hepatic involvement presenting concomitantly with pancreatic adenocarcinoma.
    Al-Saheli ZI; Bazzi T; Barthel B
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414341
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [A Case of braf V600E-Mutant Colorectal cancer Treated Effectively by Encorafenib, Binimetinib, and Cetuximab Triple Therapy].
    Sakamoto S; Tagai N; Shimada M; Kurebayashi H; Sawai K; Morikawa M; Koneri K; Tamaki M; Murakami M; Hirono Y; Goi T
    Gan To Kagaku Ryoho; 2022 Oct; 49(10):1145-1147. PubMed ID: 36281614
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of pancreatic Cysts.
    Paniccia A; Polanco PM; Boone BA; Wald AI; McGrath K; Brand RE; Khalid A; Kubiliun N; O'Broin-Lennon AM; Park WG; Klapman J; Tharian B; Inamdar S; Fasanella K; Nasr J; Chennat J; Das R; DeWitt J; Easler JJ; Bick B; Singh H; Fairley KJ; Sarkaria S; Sawas T; Skef W; Slivka A; Tavakkoli A; Thakkar S; Kim V; Vanderveldt HD; Richardson A; Wallace MB; Brahmbhatt B; Engels M; Gabbert C; Dugum M; El-Dika S; Bhat Y; Ramrakhiani S; Bakis G; Rolshud D; Millspaugh G; Tielleman T; Schmidt C; Mansour J; Marsh W; Ongchin M; Centeno B; Monaco SE; Ohori NP; Lajara S; Thompson ED; Hruban RH; Bell PD; Smith K; Permuth JB; Vandenbussche C; Ernst W; Grupillo M; Kaya C; Hogg M; He J; Wolfgang CL; Lee KK; Zeh H; Zureikat A; Nikiforova MN; Singhi AD
    Gastroenterology; 2023 Jan; 164(1):117-133.e7. PubMed ID: 36209796
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas.
    Schmitz D; Kazdal D; Allgäuer M; Trunk M; Vornhusen S; Nahm AM; Doll M; Weingärtner S; Endris V; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Budczies J; Kienle P; Magdeburg R; Hetjens S; Schirmacher P; Bergmann F; Rudi J; Stenzinger A; Volckmar AL
    Genes Chromosomes Cancer; 2021 Jul; 60(7):489-497. PubMed ID: 33686791
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic pancreatic Adenocarcinoma.
    Botrus G; Kosirorek H; Sonbol MB; Kusne Y; Uson Junior PLS; Borad MJ; Ahn DH; Kasi PM; Drusbosky LM; Dada H; Surapaneni PK; Starr J; Ritter A; McMillan J; Wylie N; Mody K; Bekaii-Saab TS
    Oncologist; 2021 Jul; 26(7):569-578. PubMed ID: 33555095
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities.
    Luchini C; Paolino G; Mattiolo P; Piredda ML; Cavaliere A; Gaule M; Melisi D; Salvia R; Malleo G; Shin JI; Cargnin S; Terrazzino S; Lawlor RT; Milella M; Scarpa A
    J Exp Clin Cancer Res; 2020 Oct; 39(1):227. PubMed ID: 33115526
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot Study.
    Gerard L; Garcia J; Gauthier A; Lopez J; Durand A; Hervieu V; Lemelin A; Chardon L; Landel V; Gibert B; Lombard-Bohas C; Payen L; Walter T
    Neuroendocrinology; 2021; 111(10):951-964. PubMed ID: 33099543
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Successful braf/MEK inhibition in a patient with
    Busch E; Kreutzfeldt S; Agaimy A; Mechtersheimer G; Horak P; Brors B; Hutter B; Fröhlich M; Uhrig S; Mayer P; Schröck E; Stenzinger A; Glimm H; Jäger D; Springfeld C; Fröhling S; Zschäbitz S
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843432
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Activation of the RAS pathway through uncommon braf mutations in mucinous pancreatic cysts without KRAS mutation.
    Ren R; Krishna SG; Chen W; Frankel WL; Shen R; Zhao W; Avenarius MR; Garee J; Caruthers S; Jones D
    Mod Pathol; 2021 Feb; 34(2):438-444. PubMed ID: 32792597
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Unmet Needs of the diagnosis, Staging, and Treatment of Gastrointestinal Tumors.
    Halama N; Haberkorn U
    Semin Nucl Med; 2020 Sep; 50(5):389-398. PubMed ID: 32768003
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift.
    Vanoli A; Perfetti V; Furlan D; Neri G; Viglio A; Sessa F; Martino M; Di Sabatino A; Solcia E; La Rosa S
    Endocr Pathol; 2020 Dec; 31(4):411-417. PubMed ID: 32388775
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. pancreatic Neoplasms With Acinar Differentiation: A Review of Pathologic and Molecular Features.
    Thompson ED; Wood LD
    Arch Pathol Lab Med; 2020 Jul; 144(7):808-815. PubMed ID: 31869246
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Differential diagnosis of pancreatic serous cystadenoma and mucinous cystadenoma: utility of textural features in combination with morphological characteristics.
    Yang J; Guo X; Zhang H; Zhang W; Song J; Xu H; Ma X
    BMC Cancer; 2019 Dec; 19(1):1223. PubMed ID: 31842793
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Study on the sensitivity of multi-slice spiral CT in diagnosis of lymph node metastasis in different lymph node stations of gastric cancer].
    Xu SH; Feng LL; Chen YM; Zhang R
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):984-989. PubMed ID: 31630498
    [No Abstract]    [Full Text] [Related]  

  • 19. Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling.
    Dreyer SB; Jamieson NB; Evers L; Duthie F; Cooke S; Marshall J; Beraldi D; Knight S; Upstill-Goddard R; Dickson EJ; Carter CR; McKay CJ; Biankin AV; Chang DK
    Chin Clin Oncol; 2019 Apr; 8(2):16. PubMed ID: 31070037
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Laparoscopic pancreaticoduodenectomy for metastatic pancreatic melanoma: A case report.
    Liu X; Feng F; Wang T; Qin J; Yin X; Meng G; Yan C; Xing Z; Duan J; Liu C; Liu J
    Medicine (Baltimore); 2018 Nov; 97(44):e12940. PubMed ID: 30383642
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.